Randomized trial of modafinil for the treatment of pathological somnolence in narcolepsy. US Modafinil in Narcolepsy Multicenter Study Group

Annals of Neurology

Abstract

Narcolepsy is a central nervous system disorder characterized by excessive daytime sleepiness and cataplexy. This placebo-controlled, double-blind, randomized, parallel-group, 18-center study assessed the efficacy and safety of modafinil, a new wake-promoting drug for treating sleepiness in narcolepsy. Subjects with narcolepsy (n = 283) received daily modafinil, 200 or 400 mg, or placebo, for 9 weeks, followed by an open-label treatment period. Subjective sleepiness was measured with the Epworth Sleepiness Scale. Objective sleepiness was assessed with the Multiple Sleep Latency Test and the Maintenance of Wakefulness Test. Level of illness was measured with the Clinical Global Impression of Change. Modafinil significantly reduced all measures of sleepiness and was associated with significant improvements in level of illness. Medication-related adverse experiences were few, dose-dependent, and mostly rated mild to moderate. Modafinil taken once daily was a very well tolerated and effective wake-promoting agent in the treatment of excessive daytime somnolence associated with narcolepsy. Modafinil demonstrated an excellent safety profile for up to 40 weeks of open-label treatment and efficacy was maintained, suggesting that tolera...Continue Reading

References

Jan 1, 1990·Journal of Clinical Neurophysiology : Official Publication of the American Electroencephalographic Society·M M MitlerJ A Koziol
Jan 1, 1990·Journal of Clinical Neurophysiology : Official Publication of the American Electroencephalographic Society·M J Thorpy
Jan 1, 1985·Journal of Cardiovascular Pharmacology·P A van Zwieten, P B Timmermans
Dec 9, 1989·Lancet·C GuilleminaultF C Grumet
Dec 1, 1994·Sleep·M BilliardS Lubin
Dec 1, 1994·Sleep·C HublinC Guilleminault
Jan 1, 1996·Behavioral Medicine·M M Mitler, J C Miller
Nov 26, 1996·Proceedings of the National Academy of Sciences of the United States of America·J S LinM Jouvet

❮ Previous
Next ❯

Citations

Dec 5, 2000·Movement Disorders : Official Journal of the Movement Disorder Society·R A HauserW McDowell Anderson
Nov 26, 2008·Psychopharmacology·Natalie L MarchantJennifer M Rusted
Nov 13, 2004·European Archives of Psychiatry and Clinical Neuroscience·Michael T SaletuBernd Saletu
Mar 31, 2011·Journal of Anesthesia·Yasuhiro MorimotoTakayo Moguchi
Jan 5, 2001·European Child & Adolescent Psychiatry·P J Santosh, E Taylor
Feb 28, 2002·Sleep & Breathing = Schlaf & Atmung·P T George
Jul 3, 2010·Obesity Surgery·Jon-Erik Cleophas HoltyDena M Bravata
Mar 9, 2006·Current Neurology and Neuroscience Reports·Yves Dauvilliers
Sep 15, 2005·Current Pain and Headache Reports·Kathryn Baker, Andre Barkhuizen
Nov 30, 2000·Current Treatment Options in Neurology·C Bassetti
Mar 9, 2004·International Journal of Psychophysiology : Official Journal of the International Organization of Psychophysiology·Sharon L MerrittWilliam O'Neill
Sep 22, 1998·Electroencephalography and Clinical Neurophysiology·M M MitlerM Hirshkowitz
Jan 5, 2002·Journal of Psychiatric Research·Geoffrey HolderEdith Holsboer-Trachsler
Dec 31, 2002·Journal of Psychosomatic Research·Wilfred R PigeonRobert J Ferguson
Feb 24, 2001·Mayo Clinic Proceedings·L E KrahnM H Silber
Oct 29, 2003·Pediatric Neurology·Thomas A Rugino, Teresa C Samsock
Jun 12, 2003·Neuromuscular Disorders : NMD·K TalbotD Hilton-Jones
May 10, 2001·Parkinsonism & Related Disorders·A RabinsteinW J. Weiner
Jun 14, 2003·Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology·C ViolaniL Ferini Strambi
Oct 29, 2003·Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology·Yves DauvilliersJacques Montplaisir
Jul 13, 1999·Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology·R B SangalC Belisle
Jan 1, 2000·Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology·R B SangalJ M Sangal
Oct 11, 2013·Lancet Neurology·Yves DauvilliersUNKNOWN HARMONY I study group
Mar 8, 2007·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Ebony R SamuelsChristopher M Bradshaw
Aug 23, 2007·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Michael J Minzenberg, Cameron S Carter
Sep 30, 2000·Journal of Sleep Research·J HarshM Mitler
Sep 6, 2000·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·C GuilleminaultD Leger
Aug 5, 2005·The New England Journal of Medicine·Charles A CzeislerUNKNOWN U.S. Modafinil in Shift Work Sleep Disorder Study Group
May 7, 2009·Journal of Palliative Medicine·Leslie BlackhallElena Farace
Mar 31, 2011·Journal of Neurotrauma·Raffaele NardoneStefan Golaszewski
Jan 26, 2005·The Journal of Head Trauma Rehabilitation·Mark YlvisakerBonnie Todis
Oct 2, 2003·Clinical Neuropharmacology·Jonathan R L SchwartzRod J Hughes
Apr 20, 2004·Clinical Neuropharmacology·Murray H Rosenthal, Sharon L Bryant
Jul 4, 2001·Journal of Clinical Neurophysiology : Official Publication of the American Electroencephalographic Society·S OvereemG J Lammers
Jan 8, 2004·Journal of Clinical Psychopharmacology·Charles DeBattistaJennifer Poirier
Jan 17, 2007·Journal of Clinical Psychopharmacology·Indu TanejaDavid Robertson
Sep 22, 2006·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·M BilliardUNKNOWN EFNS Task Force

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.